Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.3004
-0.0547 (-15.40%)
At close: Jun 27, 2025, 4:00 PM
0.3500
+0.0496 (16.51%)
After-hours: Jun 27, 2025, 7:53 PM EDT
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $20.14 million as of June 27, 2025. Its market cap has decreased by -90.30% in one year.
Market Cap
20.14M
Enterprise Value
-49.84M
1-Year Change
-90.30%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $20.14M, a decrease of -98.12%. That is a compound annual growth rate of -54.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 20.14M | -71.56% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.41B |
| Johnson & Johnson | 367.12B |
| AbbVie | 329.79B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.77B |
| Abbott Laboratories | 232.77B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |